Transparency into peer practices may curb care overuse. But just prescribing fewer antibiotics isn't a simple solution.
Oliver Wyman research highlights key treatment decision and prevalence of avoidable care.
Maximize Value
August 03, 2017
No, Value-Based Payments Aren't Doomed
Why is the shift to value taking so long? And where are the promised results? There's nothing wrong with the model; the problem is in execution and implementation.
Understanding clinical variation is key to identifying inappropriate care; addressing inappropriate care is key to reducing costs and improving quality.
Maximize Value
April 27, 2017
Preparing for MACRA: Five Things to Know Now
As provider organizations prepare for MACRA, they should consider these five workforce and organizational issues.
A comprehensive view of the ACO market, including a detailed look at “winners”, regional differences, and success rates by type.
Transform Care
February 16, 2017
New Analysis: The ACO Landscape Today
Oliver Wyman analysis details the performance of ACOs by type (physician-led, hospital-led, commercial) and offers insight into what it will take for each to be successful.
Maximize Value
January 16, 2017
Providers’ Repeal-and-Replace Playbook
Although the details and timing of repeal-and-replace are as yet unknown, providers can still begin preparing for change.
Maximize Value
November 16, 2016
Value-Based Care Under President-Elect Trump? Here to Stay
Why the path to value remains necessary to offset the high-cost/low-quality formula – no matter who is sitting in the White House.
Oliver Wyman's Chief Medical Officer breaks down how healthcare providers may be impacted by an ACA repeal.
